Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Income Statement

Financials in millions USD. Fiscal year is November - October.

Year	2023	2022	2021	2020	2019
Revenue	16.98	19.4	20.12	21.56	19.51
Revenue Growth (YoY)	-12.48%	-3.56%	-6.72%	10.55%	9.61%
Cost of Revenue	11.91	14.52	14.76	14.9	13.33
Gross Profit	5.07	4.88	5.36	6.67	6.18
Selling, General & Admin	3.95	3.71	9.21	4.44	4.48
Other Operating Expenses	0.57	0.01	1.98	0.06	0.53
Operating Expenses	3.95	3.71	9.21	4.44	4.48
Operating Income	1.12	1.17	-3.85	2.23	1.7
Interest Expense	0	-0.01	0	0	0
Other Expense / Income	-0.57	-	-1.98	-0.06	-0.53
Pretax Income	1.69	1.19	-1.88	2.29	2.22
Income Tax	0.38	0.18	0.21	0.24	0.14
Net Income	1.31	1.01	-2.09	2.05	2.09
Net Income Growth	30.15%	-	-	-1.74%	63.10%
Shares Outstanding (Basic)	23	23	23	23	23
Shares Outstanding (Diluted)	23	23	23	23	23
Shares Change	-0.15%	0.02%	-0.06%	-0.32%	0.08%
EPS (Basic)	0.06	0.04	-0.09	0.09	0.09
EPS (Diluted)	0.06	0.04	-0.09	0.09	0.09
EPS Growth	30.43%	-	-	-1.44%	63.00%
Free Cash Flow	1.88	0.57	0.79	1.47	-2.27
Free Cash Flow Per Share	0.08	0.02	0.03	0.06	-0.10
Gross Margin	29.84%	25.16%	26.65%	30.92%	31.66%
Operating Margin	6.58%	6.06%	-19.16%	10.32%	8.70%
Profit Margin	7.72%	5.19%	-10.39%	9.51%	10.70%
Free Cash Flow Margin	11.10%	2.95%	3.95%	6.82%	-11.61%
Effective Tax Rate	22.36%	15.29%	-	10.44%	6.12%
EBITDA	1.31	1.23	-3.78	2.31	1.8
EBITDA Margin	7.73%	6.32%	-18.80%	10.72%	9.21%
Depreciation & Amortization	0.19	0.05	0.07	0.09	0.1
EBIT	1.12	1.17	-3.85	2.23	1.7
EBIT Margin	6.58%	6.06%	-19.16%	10.32%	8.70%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.